Skip to main content
. Author manuscript; available in PMC: 2018 May 31.
Published in final edited form as: Cancer Res. 2011 Sep 12;71(21):6665–6675. doi: 10.1158/0008-5472.CAN-11-1590

Figure 3. Survival is Shortened in Kras-Tgfbr2−/− Mice.

Figure 3

After administration of Ad.Cre, animals were followed until death or moribund condition. Kaplan Meier survival curve indicates median survival of Kras-Tgfbr2−/− mice was 43 days vs. 79 days in the Kras-Tgfbr2WT animals, P < .001.